Multiplex Nested PCR for Preimplantation Genetic Diagnosis of Spinal Muscular Atrophy
Authors:
- Tamar SchwartzTSTamar Schwartz
- Nava Mei-RazNMNava Mei-Raz
- Dalit Ben YosefDYDalit Ben Yosef
- Ami AmitAAAmi Amit
- Joseph B. LessingJLJoseph B. Lessing
- Ruth ShomratRSRuth Shomrat
- Avi Orr-UrtregerAOAvi Orr-Urtreger
- Yuval YaronYYYuval Yaron
- 13 February 2004
- journal article
- case report
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 19 (2) , 199-206
Abstract
Objective: Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder caused in most patients by homozygous deletion of the SMN1 gene. For a carrier couple at a 25% risk of affected offspring, preimplantation genetic diagnosis (PGD) offers an alternative to prenatal diagnosis and termination of affected pregnancies. Our objective was to develop an accurate and reliable single-cell multiplex nested PCR analysis for PGD of SMA. Methods: The method was developed on single blood leukocytes, obtained from healthy controls and an adult SMA type III patient with a known homozygous deletion of SMN1 exon 7 and 8. Multiplex nested PCR on single cells was used to co-amplify exons 7 and 8 of SMN. Additional multiplexing was performed with the ZFX/ZFY gene for sexing. Following successful establishment of the multiplex nested PCR protocol in single leukocytes, the technique was employed for PGD in 4 patients for a total of 7 cycles. In 2 patients, sexing was simultaneously performed using ZFX/ZFY. Results: 220 single leukocytes from a normal individual and 220 from an SMA patient were analyzed. Exon 7 of SMN1 was amplified in 99% of normal single leukocytes and in none of the SMA-affected leukocytes. Exon 7 of SMN2 was amplified in 100% of both normal and SMA-affected leukocytes. Exon 8 of SMN1 was amplified in 98% of normal cells and in none of the SMA-affected leukocytes. Exon 8 of SMN2 was amplified in 96% of both normal and SMA-affected leukocytes. Amplification efficiency was 99% for ZFX/ZFY. There were no false-negative results and no contamination was detected in all wash-drop blanks tested. Seven PGD cycles were performed in 4 SMA-carrier couples with successful molecular analysis of 34 embryos and a total of 15 normal embryos transferred in 7 cycles. One clinical pregnancy has resulted in the delivery of a healthy male. Amniocentesis performed at 17 weeks confirmed the correct diagnosis for both SMA and sexing. Conclusions: These results suggest that our multiplex nested PCR protocol offers an efficient and accurate method for PGD of SMA while enabling the simultaneous analysis of an additional loci.Keywords
This publication has 9 references indexed in Scilit:
- Allele-specific amplification for preimplantation genetic diagnosis (PGD) of spinal muscular atrophyPrenatal Diagnosis, 2001
- Quantitative Analysis of Survival Motor Neuron Copies: Identification of Subtle SMN1 Mutations in Patients with Spinal Muscular Atrophy, Genotype-Phenotype Correlation, and Implications for Genetic CounselingThe American Journal of Human Genetics, 1999
- Preimplantation genetic diagnosis: strategies and surprisesTrends in Genetics, 1997
- Structure and Organization of the Human Survival Motor Neurone (SMN) GeneGenomics, 1996
- HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loadingCell, 1995
- PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophyThe Lancet, 1995
- Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14The Lancet, 1990
- Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q1 1.2–13.3Nature, 1990
- CLASSIFICATION OF SPINAL MUSCULAR ATROPHIESThe Lancet, 1980